INHC — Induction Healthcare Income Statement
0.000.00%
Last trade - 00:00
- £14.32m
- £11.35m
- £12.88m
- 32
- 46
- 36
- 28
2019 March 31st | 2020 March 31st | C2021 March 31st | R2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0.148 | 1.36 | 7.23 | 12.9 |
Cost of Revenue | |||||
Gross Profit | -0.066 | 0.075 | 0.725 | 4.48 | 8.13 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.71 | 3.72 | 9.38 | 16.4 | 30.3 |
Operating Profit | -2.71 | -3.57 | -8.02 | -9.13 | -17.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.71 | -3.53 | -8.12 | -9.16 | -17.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.71 | -3.53 | -7.61 | -8.08 | -16.6 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -2.71 | -3.53 | -7.61 | -8.43 | -17.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.71 | -3.53 | -7.61 | -8.43 | -17.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.074 | -0.116 | -0.176 | -0.101 | -0.125 |